Herein, we demonstrate for the first time that the combined usage of GTE with taxol (Figure 1(d)), cisplatin (Supplementary Figure S3), or doxorubicin (data not shown) results in synergistic growth inhibition of HER2-overexpressing cancer cells. This evidence concerns the gene ERBB2 and cancer.